TrialOncotarget2016

Phase I/II study of azacitidine and capecitabine/oxaliplatin (CAPOX) in refractory CIMP-high metastatic colorectal cancer: evaluation of circulating methylated vimentin.

Michael J Overman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.